Markets:

Overview

News

Currencies

International

Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

16.21 -0.35 (-2.11%)

Streaming Delayed Price Updated: 10:41 AM EDT, Apr 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares

February 07, 2023

From MediWound Ltd.

Via GlobeNewswire

MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market

February 03, 2023

From MediWound Ltd.

Via GlobeNewswire

Starbucks To Rally 11%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

January 04, 2023

UBS cut Microsoft Corporation (NASDAQ: MSFT) price target from $300 to $250. UBS analyst Karl Keirstead downgraded the stock from Buy to Neutral. Microsoft shares fell 2% to $234.73 in pre-market...

Via Benzinga

Cowen & Co. Maintains Outperform Rating for MediWound: Here's What You Need To Know ↗

December 30, 2022

Via Benzinga

FDA Approves MediWound's NexoBrid For Burn Treatment ↗

December 30, 2022

Via Benzinga

Recap: MediWound Q2 Earnings ↗

August 09, 2022

MediWound (NASDAQ:MDWD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults

December 29, 2022

From MediWound Ltd.

Via GlobeNewswire

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗

December 27, 2022

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

Via Benzinga

MediWound Expands NexoBrid’s Global Presence with Marketing Approval in Japan

December 23, 2022

From MediWound Ltd.

Via GlobeNewswire

MediWound Strengthens European Presence of NexoBrid®

December 20, 2022

From MediWound Ltd.

Via GlobeNewswire

MediWound Posts Early Data From Non-Melanoma Skin Cancer Trial ↗

July 11, 2022

Via Benzinga

MediWound's EscharEx Shows Safe, Effective, Rapid Debridement Of Leg Ulcers ↗

July 07, 2022

Via Benzinga

MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma

December 19, 2022

From MediWound Ltd.

Via GlobeNewswire

MediWound Expands Global Presence as NexoBrid® Gains Approval in India

December 13, 2022

Exclusive marketing and distribution agreement signed with Bharat Serum and Vaccines Limited (BSV), a leading biopharmaceutical company

From MediWound Ltd.

Via GlobeNewswire

MediWound Announces a 1-for-7 Reverse Share Split

December 05, 2022

From MediWound Ltd.

Via GlobeNewswire

MediWound: Q1 Earnings Insights ↗

May 17, 2022

MediWound (NASDAQ:MDWD) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For November 15, 2022 ↗

November 15, 2022

Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.

Via Benzinga

MediWound to Report Third Quarter 2022 Financial Results

November 03, 2022

Conference Call and Webcast Scheduled for Tuesday, November 15, 2022 at 8:30 am Eastern Time

From MediWound Ltd.

Via GlobeNewswire

MediWound Announces Formation of Strategic Advisory Board

October 25, 2022

Esteemed group of industry leaders to contribute expertise and experience to MediWound’s strategic and operational activities

From MediWound Ltd.

Via GlobeNewswire

MediWound's EscharEx® Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022

October 18, 2022

EscharEx’s promising results from the completed Phase 2 trials were highlighted

From MediWound Ltd.

Via GlobeNewswire

MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings

October 07, 2022

Gross Proceeds of $30.5 Million Raised

From MediWound Ltd.

Via GlobeNewswire

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Dow Turns Higher; Crude Oil Rises 0.7% ↗

September 22, 2022

U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday.

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher ↗

September 22, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday.

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

FDA Accepts MediWound's Refiling For Severe Thermal Burns Therapy For Review ↗

August 03, 2022

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For May 17, 2022 ↗

May 17, 2022

Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter.

Via Benzinga

Preview: MediWound's Earnings ↗

May 16, 2022

MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that MediWound will...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.